Trials / Completed
CompletedNCT03776318
Long-Term Follow-up Safety of Clonidine Micropellets
A Multicenter, Randomized, Follow-up Study to Evaluate the Long-Term Safety of Clonidine Micropellets for the Treatment of Pain Associated With Lumbosacral Radiculopathy in Adults
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (actual)
- Sponsor
- Sollis Therapeutics, Inc. · Industry
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
Long-term follow-up study to evaluate the safety of clonidine micropellets up to 12 months post injection.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Long-Term Safety Follow-up | STX-015-18-01 long-term safety follow-up |
Timeline
- Start date
- 2018-11-15
- Primary completion
- 2021-01-22
- Completion
- 2021-05-31
- First posted
- 2018-12-14
- Last updated
- 2023-10-06
Locations
25 sites across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03776318. Inclusion in this directory is not an endorsement.